A 48-year-old man with obesity (BMI 33 kg/m2), type 2 diabetes, and hypertension presents for follow-up. His hemoglobin A1c is 8.5 percent despite met...

Question

A 48-year-old man with obesity (BMI 33 kg/m2), type 2 diabetes, and hypertension presents for follow-up. His hemoglobin A1c is 8.5 percent despite metformin at maximum dose. eGFR is 70 mL/min/1.73 m2. He has no history of heart failure or chronic kidney disease. Which agent is most appropriate to add for additional glycemic control while also promoting weight loss?

Accepted Answer

Glucagon-like peptide-1 receptor agonist

Answer

Basal insulin

Answer

Sulfonylurea

Answer

Dipeptidyl peptidase-4 inhibitor

Answer

Thiazolidinedione

us-abfm MCQ (SBA): Type 2 diabetes therapy intensification